These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 24139497

  • 1. Childhood asthma clusters and response to therapy in clinical trials.
    Chang TS, Lemanske RF, Mauger DT, Fitzpatrick AM, Sorkness CA, Szefler SJ, Gangnon RE, Page CD, Jackson DJ, Childhood Asthma Research and Education (CARE) Network Investigators.
    J Allergy Clin Immunol; 2014 Feb; 133(2):363-9. PubMed ID: 24139497
    [Abstract] [Full Text] [Related]

  • 2. Predictors of asthma control and lung function responsiveness to step 3 therapy in children with uncontrolled asthma.
    Rabinovitch N, Mauger DT, Reisdorph N, Covar R, Malka J, Lemanske RF, Morgan WJ, Guilbert TW, Zeiger RS, Bacharier LB, Szefler SJ.
    J Allergy Clin Immunol; 2014 Feb; 133(2):350-6. PubMed ID: 24084071
    [Abstract] [Full Text] [Related]

  • 3. Management of Asthma in School age Children On Therapy (MASCOT): a randomised, double-blind, placebo-controlled, parallel study of efficacy and safety.
    Lenney W, McKay AJ, Tudur Smith C, Williamson PR, James M, Price D, MASCOT Study Group.
    Health Technol Assess; 2013 Feb; 17(4):1-218. PubMed ID: 23380178
    [Abstract] [Full Text] [Related]

  • 4. Montelukast and fluticasone compared with salmeterol and fluticasone in protecting against asthma exacerbation in adults: one year, double blind, randomised, comparative trial.
    Bjermer L, Bisgaard H, Bousquet J, Fabbri LM, Greening AP, Haahtela T, Holgate ST, Picado C, Menten J, Dass SB, Leff JA, Polos PG.
    BMJ; 2003 Oct 18; 327(7420):891. PubMed ID: 14563743
    [Abstract] [Full Text] [Related]

  • 5. Step-up therapy for children with uncontrolled asthma receiving inhaled corticosteroids.
    Lemanske RF, Mauger DT, Sorkness CA, Jackson DJ, Boehmer SJ, Martinez FD, Strunk RC, Szefler SJ, Zeiger RS, Bacharier LB, Covar RA, Guilbert TW, Larsen G, Morgan WJ, Moss MH, Spahn JD, Taussig LM, Childhood Asthma Research and Education (CARE) Network of the National Heart, Lung, and Blood Institute.
    N Engl J Med; 2010 Mar 18; 362(11):975-85. PubMed ID: 20197425
    [Abstract] [Full Text] [Related]

  • 6. Effect of fluticasone 250 microg/salmeterol 50 microg and montelukast on exhaled nitric oxide in asthmatic patients.
    Gelb AF, Taylor CF, Shinar CM, Gutierrez CA, Zamel N.
    Can Respir J; 2008 Mar 18; 15(4):193-8. PubMed ID: 18551200
    [Abstract] [Full Text] [Related]

  • 7. Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial).
    Bjermer L, Bisgaard H, Bousquet J, Fabbri LM, Greening A, Haahtela T, Holgate ST, Picado C, Leff JA.
    Respir Med; 2000 Jun 18; 94(6):612-21. PubMed ID: 10921768
    [Abstract] [Full Text] [Related]

  • 8. Montelukast, compared with fluticasone, for control of asthma among 6- to 14-year-old patients with mild asthma: the MOSAIC study.
    Garcia Garcia ML, Wahn U, Gilles L, Swern A, Tozzi CA, Polos P.
    Pediatrics; 2005 Aug 18; 116(2):360-9. PubMed ID: 16061590
    [Abstract] [Full Text] [Related]

  • 9. [A fixed combination of fluticasone and salmeterol permits better control of asthma than a beclomethasone dipropionate and montelukast combination].
    Grosclaude M, Cerruti JL, Delannay B, Hérent M, Spilthooren F, Desfougères JL.
    Eur Ann Allergy Clin Immunol; 2003 Nov 18; 35(9):356-62. PubMed ID: 14716965
    [Abstract] [Full Text] [Related]

  • 10. Salmeterol/fluticasone propionate (50/500 microg) in combination in a Diskus inhaler (Seretide) is effective and safe in the treatment of steroid-dependent asthma.
    Aubier M, Pieters WR, Schlösser NJ, Steinmetz KO.
    Respir Med; 1999 Dec 18; 93(12):876-84. PubMed ID: 10653049
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study.
    Maspero J, Guerra F, Cuevas F, Gutierrez JP, Soto-Ramos M, Anderton S, Mechali D, Chan R, Pedersen S.
    Clin Ther; 2008 Aug 18; 30(8):1492-504. PubMed ID: 18803991
    [Abstract] [Full Text] [Related]

  • 12. Effect of fluticasone propionate and salmeterol in a single device, fluticasone propionate, and montelukast on overall asthma control, exacerbations, and costs.
    O'Connor RD, Stanford R, Crim C, Yancey SW, Edwards L, Rickard KA, Dorinsky P.
    Ann Allergy Asthma Immunol; 2004 Dec 18; 93(6):581-8. PubMed ID: 15609769
    [Abstract] [Full Text] [Related]

  • 13. Randomized comparison of strategies for reducing treatment in mild persistent asthma.
    American Lung Association Asthma Clinical Research CentersWake Forest University, Winston-Salem, NC, USA., Peters SP, Anthonisen N, Castro M, Holbrook JT, Irvin CG, Smith LJ, Wise RA.
    N Engl J Med; 2007 May 17; 356(20):2027-39. PubMed ID: 17507702
    [Abstract] [Full Text] [Related]

  • 14. Airway mechanics after withdrawal of a leukotriene receptor antagonist in children with mild persistent asthma: Double-blind, randomized, cross-over study.
    Kim JH, Lee S, Shin YH, Ha EK, Lee SW, Kim MA, Yoon JW, Baek HS, Choi SH, Han MY.
    Pediatr Pulmonol; 2020 Dec 17; 55(12):3279-3286. PubMed ID: 32965787
    [Abstract] [Full Text] [Related]

  • 15. Characterization of within-subject responses to fluticasone and montelukast in childhood asthma.
    Szefler SJ, Phillips BR, Martinez FD, Chinchilli VM, Lemanske RF, Strunk RC, Zeiger RS, Larsen G, Spahn JD, Bacharier LB, Bloomberg GR, Guilbert TW, Heldt G, Morgan WJ, Moss MH, Sorkness CA, Taussig LM.
    J Allergy Clin Immunol; 2005 Feb 17; 115(2):233-42. PubMed ID: 15696076
    [Abstract] [Full Text] [Related]

  • 16. Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma.
    Pearlman DS, Stricker W, Weinstein S, Gross G, Chervinsky P, Woodring A, Prillaman B, Shah T.
    Ann Allergy Asthma Immunol; 1999 Mar 17; 82(3):257-65. PubMed ID: 10094216
    [Abstract] [Full Text] [Related]

  • 17. Cost effectiveness of fluticasone propionate plus salmeterol versus fluticasone propionate plus montelukast in the treatment of persistent asthma.
    O'Connor RD, Nelson H, Borker R, Emmett A, Jhingran P, Rickard K, Dorinsky P.
    Pharmacoeconomics; 2004 Mar 17; 22(12):815-25. PubMed ID: 15294013
    [Abstract] [Full Text] [Related]

  • 18. Effect of montelukast or salmeterol added to inhaled fluticasone on exercise-induced bronchoconstriction in children.
    Fogel RB, Rosario N, Aristizabal G, Loeys T, Noonan G, Gaile S, Smugar SS, Polos PG.
    Ann Allergy Asthma Immunol; 2010 Jun 17; 104(6):511-7. PubMed ID: 20568384
    [Abstract] [Full Text] [Related]

  • 19. Pharmacogenetics of asthma controller treatment.
    Mougey EB, Chen C, Tantisira KG, Blake KV, Peters SP, Wise RA, Weiss ST, Lima JJ.
    Pharmacogenomics J; 2013 Jun 17; 13(3):242-50. PubMed ID: 22370858
    [Abstract] [Full Text] [Related]

  • 20. Inhaled salmeterol/fluticasone propionate combination: a review of its use in persistent asthma.
    Markham A, Jarvis B.
    Drugs; 2000 Nov 17; 60(5):1207-33. PubMed ID: 11129128
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.